UNICYCIVE THERAPEUTICS INCUNCY
ASignal's systematic analysis rates UNCY as Neutral.
Reflects the latest available analysis · analyzed Oct 19, 2026
The case on UNCY
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Strong cash position with $61.42M in total cash
- Low debt-to-equity ratio of 0.01x indicating minimal leverage
- Current ratio of 3.81x suggests solid short-term financial health
- RSI at 20.95 indicates oversold condition, potential for rebound
- Negative MACD histogram and MACD below signal line suggest ongoing downtrend
- Price trading well below SMA20 and SMA50, indicating strong technical weakness
- Negative price momentum of -0.17
- Negative return on equity (-101.07%) and negative return on assets (-40.59%)
- Negative operating and free cash flow
- Extremely low news coverage with only one source (Yahoo)
See the full verdict on UNCY
ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.
How ASignal analyzes UNCY
Most investors never get a second opinion, let alone several. ASignal runs UNCY past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.